{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:34:33Z","timestamp":1760132073473},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"23-24","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s10354-009-0724-2","type":"journal-article","created":{"date-parts":[[2010,2,11]],"date-time":"2010-02-11T12:52:25Z","timestamp":1265892745000},"page":"566-570","source":"Crossref","is-referenced-by-count":5,"title":["Nasale Anwendung von Fentanylzitrat zur Kupierung von Atemnot in der Palliativversorgung \u2013 \u00dcberblick und Fallbeispiel"],"prefix":"10.1007","volume":"159","author":[{"given":"Thomas","family":"Sitte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"724_CR1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1055\/s-2007-986261","volume":"8","author":"M Kern","year":"2007","unstructured":"Kern M, Ostgathe E, Wessel H. Ambulante palliative Betreuung in Bonn \u2013 Einflussfaktoren auf eine station\u00e4re Einweisung am Lebensende. Z f Palliativmedizin, 8: 155\u2013161, 2007","journal-title":"Z f Palliativmedizin"},{"key":"724_CR2","doi-asserted-by":"crossref","unstructured":"Jennings AL, Davies AN, Higgins JP, Broadley K. Opioids for the palliation of breathlessness in terminal illness. [Review] [70 refs]. Cochrane Database of Systematic Reviews (4):CD002066, 2001","DOI":"10.1002\/14651858.CD002066"},{"key":"724_CR3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/bmj.327.7414.523","volume":"327","author":"AP CD Abernethy","year":"2003","unstructured":"Abernethy AP CD, Frith P, Fazekas BS, McHugh A, Chuong B. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ, 327: 523\u2013528, 2003","journal-title":"BMJ"},{"key":"724_CR4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.7326\/0003-4819-148-2-200801150-00009","volume":"148","author":"A Qaseem","year":"2008","unstructured":"Qaseem A, Snow V, Shekelle P, Casey D, Cross T, Owens D. Evidence-based interventions to improve the palliative care of pain, dyspnea, and depression at the end of life: a clinical practice guideline from the American College of Physicians. Ann Intern Med, 148: 141\u2013146, 2008","journal-title":"Ann Intern Med"},{"key":"724_CR5","volume-title":"Effect of nebulized fentanyl in patients with refractory dyspnea","author":"SM Burburan","year":"2009","unstructured":"Burburan SM. Effect of nebulized fentanyl in patients with refractory dyspnea. Vortrag EAPC, Wien, 2009"},{"key":"724_CR6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jpainsymman.2008.08.002","volume":"36","author":"T Sitte","year":"2008","unstructured":"Sitte T, Bausewein C. Intranasal fentanyl for episodic breathlessness. J Pain Symptom Manage, 36: 3\u20136, 2008","journal-title":"J Pain Symptom Manage"},{"key":"724_CR7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/s-2007-986254","volume":"8","author":"KE Clemens","year":"2007","unstructured":"Clemens KE, Klaschik E. Diagnostik und Therapie der Atemnot in der Palliativmedizin. Z Palliativmed, 8: 141\u2013154, 2007","journal-title":"Z Palliativmed"},{"key":"724_CR8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0885-3924(01)00391-8","volume":"23","author":"PJ Coyne","year":"2002","unstructured":"Coyne PJ, Viswanathan R, Smith TJ. Nebulized fentanyl citrate improves patients' perception of breathing, respiratory rate, and oxygen saturation in dyspnea. J Pain Symptom Manage, 23: 157\u2013160, 2002","journal-title":"J Pain Symptom Manage"},{"key":"724_CR9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jpainsymman.2005.10.002","volume":"30","author":"MA Benitez-Rosario","year":"2005","unstructured":"Benitez-Rosario MA, Martin AS, Feria M. Oral transmucosal fentanyl citrate in the management of dyspnea crises in cancer patients. J Pain Symptom Manage, 30: 395\u2013397, 2005","journal-title":"J Pain Symptom Manage"},{"key":"724_CR10","unstructured":"Arzneimittelkommission d. Deutschen Apotheker. Neues Rezeptur-Formularium (NRF). Eschborn, Govi-Verlag. ISBN-10: 3774100101"},{"issue":"7","key":"724_CR11","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1034\/j.1399-6576.2002.460702.x","volume":"46","author":"O Dale","year":"2002","unstructured":"Dale O, Hjortkjaer R, Kharasch ED. Nasal administration of opioids for pain management in adults. Acta Anaesthesiol Scand, 46(7): 759\u2013770, 2002","journal-title":"Acta Anaesthesiol Scand"},{"key":"724_CR12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0885-3924(00)00180-9","volume":"20","author":"G Zeppetella","year":"2000","unstructured":"Zeppetella G. An assessment of the safety, efficacy, and acceptability of intranasal fentanyl citrate in the management of cancer-related breakthrough pain: a pilot study. J Pain Symptom Manage, 20: 253\u2013258, 2000","journal-title":"J Pain Symptom Manage"},{"key":"724_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1018911206646","volume":"9","author":"MA Sarkar","year":"1992","unstructured":"Sarkar MA. Drug metabolism in the nasal mucosa. Pharm Res, 9: 1\u20139, 1992","journal-title":"Pharm Res"},{"key":"724_CR14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1399-6576.1997.tb04684.x","volume":"41","author":"A Takala","year":"1997","unstructured":"Takala A, Kaasalainen V, Seppala T, Kalso E, Olkkola KT. Pharmacokinetic comparison of intravenous and intranasal administration of oxycodone. Acta Anaesthesiol Scand, 41: 309\u2013312, 1997","journal-title":"Acta Anaesthesiol Scand"},{"key":"724_CR15","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.2042-7158.1989.tb06374.x","volume":"41","author":"J Eriksen","year":"1989","unstructured":"Eriksen J, Jensen NH, Kamp-Jensen M, Bjarno H, Friis P, Brewster D. The systemic availability of buprenorphine administered by nasal spray. J Pharm Pharmacol, 41: 803\u2013805, 1989","journal-title":"J Pharm Pharmacol"},{"key":"724_CR16","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/BF02527870","volume":"7","author":"HW Striebel","year":"1993","unstructured":"Striebel HW, Kramer J, Luhmann I, Rohierse-Hohler I, Rieger A. [Pharmacokinetics of intranasal Fentanyl.]. Schmerz, 7: 122\u2013125, 1993","journal-title":"Schmerz"},{"issue":"1","key":"724_CR17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/jppr200333159","volume":"33","author":"S Lim","year":"2003","unstructured":"Lim S, Paech MJ, Sunderland B, Robert MJ, Banks SL, Rucklidge MWM. Pharmacokinetics of nasal fentanyl. J Pharm Pract Res, 33(1): 59\u201363, 2003","journal-title":"J Pharm Pract Res"},{"key":"724_CR18","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1034\/j.1399-6576.2002.460702.x","volume":"46","author":"O Dale","year":"2002","unstructured":"Dale O, Hjortkjaer R, Kharasch ED. Nasal administration of opioids for pain management in adults. Acta Anaesthesiol Scand, 46: 759\u2013770, 2002","journal-title":"Acta Anaesthesiol Scand"},{"key":"724_CR19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00000542-199208000-00010","volume":"77","author":"HW Striebel","year":"1992","unstructured":"Striebel HW, Koenigs D, Kramer J. Postoperative pain management by intranasal demand-adapted fentanyl titration. Anesthesiology, 77: 281\u2013285, 1992","journal-title":"Anesthesiology"},{"key":"724_CR20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0885-3924(00)00180-9","volume":"20","author":"G Zeppetella","year":"2000","unstructured":"Zeppetella G. An assessment of the safety, efficacy, and acceptability of intranasal fentanyl citrate in the management of cancer-related breakthrough pain: a pilot study. J Pain Symptom Manage, 20: 253\u2013258, 2000","journal-title":"J Pain Symptom Manage"},{"key":"724_CR21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jpainsymman.2008.08.002","volume":"36","author":"T Sitte","year":"2008","unstructured":"Sitte T, Bausewein C. Intranasal fentanyl for episodic breathlessness. J Pain Symptom Manage, 36: 3\u20136, 2008","journal-title":"J Pain Symptom Manage"},{"key":"724_CR22","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.clinthera.2008.03.001","volume":"30","author":"LL Christrup","year":"2008","unstructured":"Christrup LL, Foster D, Popper LD, Troen T, Upton R. Pharmacokinetics, efficacy, and tolerability of fentanyl following intranasal versus intravenous administration in adults undergoing third-molar extraction: A randomized, double-blind, double-dummy, two-way, crossover study. Clin Ther, 30: 469\u2013481, 2008","journal-title":"Clin Ther"},{"key":"724_CR23","doi-asserted-by":"crossref","unstructured":"Portenoy R, Wallace M, Taylor D, Rauck R, Galan V, Burton A, on behalf of the Fentanyl Nasal Spray Study 043 Investigators Group. Fentanyl Pectin Nasal Spray (FPNS) with PecSys\u00ae: efficacy, tolerability and onset of action in the treatment of Breakthrough Cancer Pain (BTCP). Posterbeitrag, Jahrestagung APS 5\/2009","DOI":"10.1016\/j.jpain.2009.01.153"},{"key":"724_CR24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/0269216307076714","volume":"21","author":"R George","year":"2007","unstructured":"George R, Regnard C. Lethal opioids or dangerous prescribers. Pall Med, 21: 77\u201380, 2007","journal-title":"Pall Med"},{"key":"724_CR25","unstructured":"Clemens K, Klaschik E. Sauerstoffinsufflation versus Opiodapplikation bei Dyspnoe. Posterbeitrag. Palliativkongress 2008, Wiesbaden"},{"key":"724_CR26","doi-asserted-by":"crossref","unstructured":"Wiese C, Bartels U, Nauck F, Graf B, Hanekop G. Not\u00e4rztliche Behandlung von Palliativpatienten im weit fortgeschrittenen Krankheitsstadium mit Dyspnoe. Posterbeitrag, Palliativkongress 2008, Wiesbaden","DOI":"10.1055\/s-0028-1088509"},{"key":"724_CR27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1055\/s-2007-986261","volume":"8","author":"M Kern","year":"2007","unstructured":"Kern M, Ostgathe E, Wessel H. Ambulante palliative Betreuung in Bonn \u2013 Einflussfaktoren auf eine station\u00e4re Einweisung am Lebensende. Z f Palliativmedizin, 8: 155\u2013161, 2007","journal-title":"Z f Palliativmedizin"},{"key":"724_CR28","series-title":"Handbuch f\u00fcr die Schmerztherapie","volume-title":"Analgetika, Antinozizeptiva, Adjuvantien","author":"HH Waldvogel","year":"2004","unstructured":"Waldvogel HH. Analgetika, Antinozizeptiva, Adjuvantien. Handbuch f\u00fcr die Schmerztherapie. Springer, Berlin Heidelberg New York, 2004"},{"key":"724_CR29","unstructured":"Produktinformation, Beipackzettel Durogesic\u00ae, 2008"},{"key":"724_CR30","unstructured":"Produktinformation, Beipackzettel Actiq\u00ae, 2008"},{"key":"724_CR31","unstructured":"Produktinformation, Beipackzettel Abstral\u00ae, 2009"},{"key":"724_CR32","unstructured":"Produktinformation, Beipackzettel Effentora\u00ae, 2009"}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-009-0724-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10354-009-0724-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-009-0724-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T16:03:51Z","timestamp":1559145831000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10354-009-0724-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":32,"journal-issue":{"issue":"23-24","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["724"],"URL":"https:\/\/doi.org\/10.1007\/s10354-009-0724-2","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"value":"0043-5341","type":"print"},{"value":"1563-258X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}